<code id='F8EB911A22'></code><style id='F8EB911A22'></style>
    • <acronym id='F8EB911A22'></acronym>
      <center id='F8EB911A22'><center id='F8EB911A22'><tfoot id='F8EB911A22'></tfoot></center><abbr id='F8EB911A22'><dir id='F8EB911A22'><tfoot id='F8EB911A22'></tfoot><noframes id='F8EB911A22'>

    • <optgroup id='F8EB911A22'><strike id='F8EB911A22'><sup id='F8EB911A22'></sup></strike><code id='F8EB911A22'></code></optgroup>
        1. <b id='F8EB911A22'><label id='F8EB911A22'><select id='F8EB911A22'><dt id='F8EB911A22'><span id='F8EB911A22'></span></dt></select></label></b><u id='F8EB911A22'></u>
          <i id='F8EB911A22'><strike id='F8EB911A22'><tt id='F8EB911A22'><pre id='F8EB911A22'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:Wikipedia    Page View:61869
          Adobe

          Private Medicare just isn’t the gold mine it once was. Case in point: Cano Health, a company once valued at $4.4 billion, is now bankrupt.

          The prospect of bankruptcy had stalked the Miami-based primary care provider for well over a year before its Chapter 11 filing on Sunday. A number of things had gone wrong. First, there was Cano’s rapid growth ahead of its 2021 initial public offering that gave way to a mountain of debt, currently sitting at $1.3 billion. Then there was public beef between its former directors and then-CEO.

          advertisement

          Most importantly, the company’s main business, Medicare Advantage, became less profitable. As evidence accumulated that the private insurers running MA plans game the system by exaggerating their members’ illnesses, the Biden administration vowed to fix the problem. This year, Medicare is phasing in a new payment model designed to reduce overpayment.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          comprehensive

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Vir antibody drug aimed at influenza A fails in clinical trial
          Vir antibody drug aimed at influenza A fails in clinical trial

          F.A.Murphy/CDCVirBiotechnologysaidThursdaythatalong-actingantibodydrugdesignedtoprotecthealthyindivi

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Indian pharmaceutical industry in denial over drug

          AchemistworksatapharmaceuticalmanufacturingplantontheoutskirtsofMumbai.Drugmakersinthecountryhavecom